[1]
Blackburn SC, Stanton MP. Anatomy and physiology of the peritoneum. Seminars in pediatric surgery. 2014 Dec:23(6):326-30. doi: 10.1053/j.sempedsurg.2014.06.002. Epub 2014 Jun 4
[PubMed PMID: 25459436]
[2]
Sampson JA. Implantation Peritoneal Carcinomatosis of Ovarian Origin. The American journal of pathology. 1931 Sep:7(5):423-444.39
[PubMed PMID: 19969977]
[3]
Klos D, Riško J, Stašek M, Loveček M, Hanuliak J, Skalický P, Lemstrová R, Mohelníková BD, Študentová H, Neoral Č, Melichar B. Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies. Casopis lekaru ceskych. 2018 Dec 17:157(8):419-428
[PubMed PMID: 30754979]
[4]
Flanagan M, Solon J, Chang KH, Deady S, Moran B, Cahill R, Shields C, Mulsow J. Peritoneal metastases from extra-abdominal cancer - A population-based study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Nov:44(11):1811-1817. doi: 10.1016/j.ejso.2018.07.049. Epub 2018 Jul 26
[PubMed PMID: 30139510]
[5]
Lengyel E. Ovarian cancer development and metastasis. The American journal of pathology. 2010 Sep:177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22
[PubMed PMID: 20651229]
[6]
Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2006 Nov:95 Suppl 1():S161-92
[PubMed PMID: 17161157]
Level 2 (mid-level) evidence
[7]
Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, Bouvier AM. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study. Diseases of the colon and rectum. 2015 Aug:58(8):743-52. doi: 10.1097/DCR.0000000000000412. Epub
[PubMed PMID: 26163953]
[8]
Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. Journal of surgical oncology. 2011 Nov 1:104(6):692-8. doi: 10.1002/jso.22017. Epub 2011 Jun 28
[PubMed PMID: 21713780]
Level 1 (high-level) evidence
[9]
Madani A, Thomassen I, van Gestel YRBM, van der Bilt JDW, Haak HR, de Hingh IHJT, Lemmens VEPP. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis. Annals of surgical oncology. 2017 Aug:24(8):2199-2205. doi: 10.1245/s10434-016-5734-x. Epub 2017 Feb 15
[PubMed PMID: 28204963]
[10]
Sereno M, Rodríguez-Esteban I, Gómez-Raposo C, Merino M, López-Gómez M, Zambrana F, Casado E. Lung cancer and peritoneal carcinomatosis. Oncology letters. 2013 Sep:6(3):705-708
[PubMed PMID: 24137394]
Level 3 (low-level) evidence
[11]
Thomassen I, Verhoeven RH, van Gestel YR, van de Wouw AJ, Lemmens VE, de Hingh IH. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin. European journal of cancer (Oxford, England : 1990). 2014 Jan:50(1):50-6. doi: 10.1016/j.ejca.2013.08.009. Epub 2013 Sep 3
[PubMed PMID: 24011935]
[12]
Solon JG, O'Neill M, Chang KH, Deady S, Cahill R, Moran B, Shields C, Mulsow J. An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Oct:43(10):1924-1931. doi: 10.1016/j.ejso.2017.05.010. Epub 2017 May 24
[PubMed PMID: 28583791]
[13]
Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World journal of gastroenterology. 2012 Oct 21:18(39):5489-94. doi: 10.3748/wjg.v18.i39.5489. Epub
[PubMed PMID: 23112540]
[14]
Mikuła-Pietrasik J, Uruski P, Tykarski A, Książek K. The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cellular and molecular life sciences : CMLS. 2018 Feb:75(3):509-525. doi: 10.1007/s00018-017-2663-1. Epub 2017 Sep 27
[PubMed PMID: 28956065]
[15]
Langley RR, Fidler IJ. The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. International journal of cancer. 2011 Jun 1:128(11):2527-35. doi: 10.1002/ijc.26031. Epub 2011 Mar 25
[PubMed PMID: 21365651]
[16]
Terzi C,Arslan NC,Canda AE, Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? World journal of gastroenterology. 2014 Oct 21;
[PubMed PMID: 25339824]
[17]
Kusamura S, Baratti D, Zaffaroni N, Villa R, Laterza B, Balestra MR, Deraco M. Pathophysiology and biology of peritoneal carcinomatosis. World journal of gastrointestinal oncology. 2010 Jan 15:2(1):12-8. doi: 10.4251/wjgo.v2.i1.12. Epub
[PubMed PMID: 21160812]
[18]
Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989 Jan 15:63(2):364-7
[PubMed PMID: 2910444]
[19]
Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000 Jan 15:88(2):358-63
[PubMed PMID: 10640968]
[20]
Jayne DG,Fook S,Loi C,Seow-Choen F, Peritoneal carcinomatosis from colorectal cancer. The British journal of surgery. 2002 Dec;
[PubMed PMID: 12445064]
[21]
Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. International seminars in surgical oncology : ISSO. 2005 Feb 8:2(1):3
[PubMed PMID: 15701175]
[22]
Valle M, Federici O, Garofalo A. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surgical oncology clinics of North America. 2012 Oct:21(4):515-31. doi: 10.1016/j.soc.2012.07.005. Epub
[PubMed PMID: 23021713]
[23]
Archer AG, Sugarbaker PH, Jelinek JS. Radiology of peritoneal carcinomatosis. Cancer treatment and research. 1996:82():263-88
[PubMed PMID: 8849956]
[24]
de Bree E,Koops W,Kröger R,van Ruth S,Witkamp AJ,Zoetmulder FA, Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. Journal of surgical oncology. 2004 May 1;
[PubMed PMID: 15112247]
[25]
Ferrandina G, Sallustio G, Fagotti A, Vizzielli G, Paglia A, Cucci E, Margariti A, Aquilani L, Garganese G, Scambia G. Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. British journal of cancer. 2009 Oct 6:101(7):1066-73. doi: 10.1038/sj.bjc.6605292. Epub 2009 Sep 8
[PubMed PMID: 19738608]
[26]
Low RN, Semelka RC, Worawattanakul S, Alzate GD. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT in 164 patients. Journal of magnetic resonance imaging : JMRI. 2000 Aug:12(2):269-77
[PubMed PMID: 10931590]
[27]
Dohan A, Hoeffel C, Soyer P, Jannot AS, Valette PJ, Thivolet A, Passot G, Glehen O, Rousset P. Evaluation of the peritoneal carcinomatosis index with CT and MRI. The British journal of surgery. 2017 Aug:104(9):1244-1249. doi: 10.1002/bjs.10527. Epub 2017 Apr 4
[PubMed PMID: 28376270]
[28]
Dresen RC, De Vuysere S, De Keyzer F, Van Cutsem E, Prenen H, Vanslembrouck R, De Hertogh G, Wolthuis A, D'Hoore A, Vandecaveye V. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer imaging : the official publication of the International Cancer Imaging Society. 2019 Jan 7:19(1):1. doi: 10.1186/s40644-018-0187-z. Epub 2019 Jan 7
[PubMed PMID: 30616608]
[29]
Klumpp BD, Schwenzer N, Aschoff P, Miller S, Kramer U, Claussen CD, Bruecher B, Koenigsrainer A, Pfannenberg C. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdominal imaging. 2013 Feb:38(1):64-71. doi: 10.1007/s00261-012-9881-7. Epub
[PubMed PMID: 22476333]
[30]
De Gaetano AM, Calcagni ML, Rufini V, Valenza V, Giordano A, Bonomo L. Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdominal imaging. 2009 May-Jun:34(3):391-402. doi: 10.1007/s00261-008-9405-7. Epub
[PubMed PMID: 18446399]
Level 3 (low-level) evidence
[31]
Bravo R, Jafari MD, Pigazzi A. The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy. American journal of clinical oncology. 2018 Dec:41(12):1231-1234. doi: 10.1097/COC.0000000000000463. Epub
[PubMed PMID: 29782364]
[32]
Song SE, Choi P, Kim JH, Jung K, Kim SE, Moon W, Park MI, Park SJ. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2018 Jun 25:71(6):332-337. doi: 10.4166/kjg.2018.71.6.332. Epub
[PubMed PMID: 29943560]
[33]
Courcoutsakis N, Tentes AA, Astrinakis E, Zezos P, Prassopoulos P. CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Abdominal imaging. 2013 Feb:38(1):56-63. doi: 10.1007/s00261-012-9869-3. Epub
[PubMed PMID: 22410875]
[34]
Najah H,Lo Dico R,Grienay M,Dohan A,Dray X,Pocard M, Single-incision flexible endoscopy (SIFE) for detection and staging of peritoneal carcinomatosis. Surgical endoscopy. 2016 Sep;
[PubMed PMID: 26659231]
[35]
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Oct 15:21(20):3737-43
[PubMed PMID: 14551293]
Level 1 (high-level) evidence
[36]
Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Annals of surgical oncology. 2008 Sep:15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3
[PubMed PMID: 18521686]
Level 1 (high-level) evidence
[37]
Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Annals of surgical oncology. 2014 Dec:21(13):4195-201. doi: 10.1245/s10434-014-3798-z. Epub 2014 May 23
[PubMed PMID: 24854493]
[39]
Sugarbaker PH. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? American journal of surgery. 2011 Feb:201(2):157-9. doi: 10.1016/j.amjsurg.2010.04.010. Epub 2010 Sep 26
[PubMed PMID: 20870209]
[40]
Sugarbaker PH. Surgical responsibilities in the management of peritoneal carcinomatosis. Journal of surgical oncology. 2010 Jun 15:101(8):713-24. doi: 10.1002/jso.21484. Epub
[PubMed PMID: 20512948]
[41]
Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL. Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database. The Journal of surgical research. 2019 Jun:238():198-206. doi: 10.1016/j.jss.2019.01.039. Epub 2019 Feb 14
[PubMed PMID: 30772678]
[42]
Elias D,Gilly F,Boutitie F,Quenet F,Bereder JM,Mansvelt B,Lorimier G,Dubè P,Glehen O, Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Jan 1;
[PubMed PMID: 19917863]
Level 2 (mid-level) evidence
[43]
Deraco M, Kusamura S, Virzì S, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Iusco DR, Baratti D. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. Gynecologic oncology. 2011 Aug:122(2):215-20. doi: 10.1016/j.ygyno.2011.05.004. Epub 2011 Jun 12
[PubMed PMID: 21665254]
[44]
Elias D, David A, Sourrouille I, Honoré C, Goéré D, Dumont F, Stoclin A, Baudin E. Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). Surgery. 2014 Jan:155(1):5-12. doi: 10.1016/j.surg.2013.05.030. Epub 2013 Sep 29
[PubMed PMID: 24084595]
[45]
Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. The British journal of surgery. 2017 May:104(6):669-678. doi: 10.1002/bjs.10521. Epub
[PubMed PMID: 28407227]
Level 1 (high-level) evidence
[46]
Hübner M,Teixeira H,Boussaha T,Cachemaille M,Lehmann K,Demartines N, [PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis]. Revue medicale suisse. 2015 Jun 17;
[PubMed PMID: 26255492]
[47]
Roti Roti JL. Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2008 Feb:24(1):3-15. doi: 10.1080/02656730701769841. Epub
[PubMed PMID: 18214765]
[48]
Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. Journal of surgical oncology. 2014 Dec:110(7):779-85. doi: 10.1002/jso.23728. Epub 2014 Aug 2
[PubMed PMID: 25088304]
[49]
Dovern E, de Hingh IH, Verwaal VJ, van Driel WJ, Nienhuijs SW. Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications. European journal of gynaecological oncology. 2010:31(3):256-61
[PubMed PMID: 21077465]
Level 2 (mid-level) evidence
[50]
van Driel WJ,Koole SN,Sikorska K,Schagen van Leeuwen JH,Schreuder HWR,Hermans RHM,de Hingh IHJT,van der Velden J,Arts HJ,Massuger LFAG,Aalbers AGJ,Verwaal VJ,Kieffer JM,Van de Vijver KK,van Tinteren H,Aaronson NK,Sonke GS, Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. The New England journal of medicine. 2018 Jan 18;
[PubMed PMID: 29342393]
[51]
Helderman RFCPA, Löke DR, Kok HP, Oei AL, Tanis PJ, Franken NAPK, Crezee J. Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review. Cancers. 2019 Jan 11:11(1):. doi: 10.3390/cancers11010078. Epub 2019 Jan 11
[PubMed PMID: 30641919]
[52]
Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel J. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Annals of surgical oncology. 2014 May:21(5):1501-5. doi: 10.1245/s10434-013-3061-z. Epub 2013 Jun 21
[PubMed PMID: 23793364]
Level 3 (low-level) evidence
[53]
Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World journal of surgical oncology. 2016 Apr 29:14():128. doi: 10.1186/s12957-016-0892-7. Epub 2016 Apr 29
[PubMed PMID: 27125996]
Level 2 (mid-level) evidence
[54]
Tempfer CB, Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. Medical hypotheses. 2015 Oct;
[PubMed PMID: 26277656]
[55]
Kurtz F, Struller F, Horvath P, Solass W, Bösmüller H, Königsrainer A, Reymond MA. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. Gastroenterology research and practice. 2018:2018():2743985. doi: 10.1155/2018/2743985. Epub 2018 Oct 24
[PubMed PMID: 30473706]
Level 2 (mid-level) evidence
[56]
Lambert LA, Hendrix RJ. Palliative Management of Advanced Peritoneal Carcinomatosis. Surgical oncology clinics of North America. 2018 Jul:27(3):585-602. doi: 10.1016/j.soc.2018.02.008. Epub
[PubMed PMID: 29935691]